← FDA DRUG APPROVALS

FDA ANDA · ANDA090397

IBUPROFEN, DIPHENHYDRAMINE HCL

Sponsor: BIONPHARMA

APPLICATION
ANDA090397
TYPE
ANDA
ORIGINAL APPROVAL
2010-11-22
LATEST ACTION
2010-11-22
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Over-the-counter

Products

IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDEOver-the-counter
DIPHENHYDRAMINE HYDROCHLORIDE 25MG, IBUPROFEN EQ 200MG FREE ACID AND POTASSIUM SALT · CAPSULE · ORAL

Approval history

2010-11-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →